Kit for screening lung cancer
A kit and reagent technology, applied in the field of lung cancer screening kits, can solve problems such as reports of no SOST expression, and achieve the effect of good clinical application prospects.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] Example 1 Detection of the expression level of SOST in lung cancer
[0025] 1. Experimental materials
[0026] Lung cancer tissue microarrays (HLugS060CD01 and HLug-Ade050CD-01) were purchased from Shanghai Xinchao Biotech. The microarray contains histopathological sections of lung cancer, including:
[0027] HLugS060CD01 tissue chip is a pathological chip of lung squamous cell carcinoma: 5 cases of normal lungs, 22 cases of adjacent / primary lung squamous cell carcinoma (clinical stage 1, 2, 3, 4), and 3 lung squamous cell carcinoma metastases Cases, 4 cases of negative / positive lymph nodes of lung squamous cell carcinoma.
[0028] HLug-Ade050CD-01 tissue chip is a pathological chip of lung adenocarcinoma: 5 cases of normal human lung, 14 cases of adjacent / primary lung adenocarcinoma (clinical stage 1, 2, 3, 4), lung gland There were 4 cases of cancer metastasis, 7 cases of negative lymph nodes and 6 cases of positive lymph nodes.
[0029] The anti-SOST polyclonal antibody was...
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com